These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6376883)

  • 1. [Current status and problems of artificial organs. 9. Artificial endocrine pancreas].
    Shichiri M; Kawamori R; Yamasaki Y
    Iyodenshi To Seitai Kogaku; 1983 Sep; 21(5):389-93. PubMed ID: 6376883
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs.
    Kono T; Hanazaki K; Yazawa K; Ashizawa S; Fisher WE; Wang XP; Nosé Y; Brunicardi FC
    Artif Organs; 2005 Jan; 29(1):83-7. PubMed ID: 15644089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of portable insulin infusion systems. IX. Biocompatibility of a needle-type micro-sensor for glucose determination].
    Hakui N
    Iyodenshi To Seitai Kogaku; 1984 Sep; 22(5):364-5. PubMed ID: 6521065
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of technology in diabetes therapy.
    Ginsberg BH
    Diabetes Care; 1994 Jun; 17 Suppl 1():50-5. PubMed ID: 8088225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trends in research and development of artificial pancreas--a projection toward the 21st century].
    Shichiri M; Kawamori R
    Nihon Rinsho; 1983; 41(3):647-60. PubMed ID: 6343673
    [No Abstract]   [Full Text] [Related]  

  • 7. [The development of glucose sensor sensing hydrogen peroxide by polarographic electrode with immobilized glucose oxidase -- Application to the artificial endocrine pancreas (author's transl)].
    Kawamori R; Shichiri M; Nomura M; Abe H; Okuyama T; Yoshida M
    Iyodenshi To Seitai Kogaku; 1980 Oct; 18(6):420-5. PubMed ID: 7024600
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell.
    Abel P; Müller A; Fischer U
    Biomed Biochim Acta; 1984; 43(5):577-84. PubMed ID: 6477543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of an "artificial pancreas" (Biostator GCIIS) for determining insulin requirement in diabetes].
    Sieradzki J; Szybiński Z
    Pol Tyg Lek; 1980 Dec; 35(49):1889-92. PubMed ID: 7017628
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery].
    Calabrese G; Bueti A; Zega G; Bellomo G; Antonella MA; Giombolini A; Tardioli F; Massi-Benedetti M; Palminiello A
    Minerva Med; 1982 Dec; 73(49-50):3509-14. PubMed ID: 7155400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the glucose-insulin system as a basis for the artificial beta cell.
    Fischer U; Salzsieder E; Jutzi E; Albrecht G; Freyse EJ
    Biomed Biochim Acta; 1984; 43(5):597-605. PubMed ID: 6383364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status and problems of artificial organs. 8. Artificial heart].
    Imachi K; Atsumi K
    Iyodenshi To Seitai Kogaku; 1983 Sep; 21(5):381-8. PubMed ID: 6376882
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of a needle-type glucose sensor for wearable artificial endocrine pancreas.
    Yamasaki Y
    Med J Osaka Univ; 1984 Sep; 35(1-2):25-34. PubMed ID: 6527668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status and problems of artificial organs. 4. Artificial heart and lung machine].
    Fukui Y
    Iyodenshi To Seitai Kogaku; 1983 Sep; 21(5):364-7. PubMed ID: 6376879
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress toward an artificial pancreas?].
    Fantoli U
    Recenti Prog Med; 1981 Apr; 70(4):437-8. PubMed ID: 7020008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the biostator (artificial pancreas) in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Mamaeva GG; Belokrinitskiĭ DV; Starosel'tseva LK; Turova EA
    Klin Med (Mosk); 1984 Oct; 62(10):55-60. PubMed ID: 6513454
    [No Abstract]   [Full Text] [Related]  

  • 20. [The development of a counterregulatory system for an artificial endocrine pancreas--invention of glucose and glucagon infusion algorithms].
    Sasai T
    Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):273-86. PubMed ID: 6862053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.